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Congenital cataracts are a major cause of bilateral visual impairment in childhood. We mapped the
gene responsible for autosomal congenital cerulean cataracts to chromosome 2q33-35 in a four gen-
eration family of Moroccan descent. The maximum lod score (7.19 at recombination fraction θ=0) was
obtained for marker D2S2208 near the γ-crystallin gene (CRYG) cluster. Sequencing of the coding
regions of the CRYGA, B, C, and D genes showed the presence of a heterozygous C>A transversion
in exon 2 of CRYGD that is associated with cataracts in this family. This mutation resulted in a proline
to threonine substitution at amino acid 23 of the protein in the first of the four Greek key motifs that
characterise this protein. We show that although the x ray crystallography modelling does not indicate
any change of the backbone conformation, the mutation affects a region of the Greek key motif that is
important for determining the topology of this protein fold. Our data suggest strongly that the proline to
threonine substitution may alter the protein folding or decrease the thermodynamic stability or solubil-
ity of the protein. Furthermore, this is the first report of a mutation in this gene resulting in autosomal
dominant congenital cerulean cataracts.
Congenital cataracts (ADCC) are a significant cause ofvisual impairment in childhood. The estimated preva-lence is 1-6/10 000 live births.1 2 In non-consanguineous
populations, most cases of inherited non-syndromic cataracts
show an autosomal dominant (AD) mode of transmission, but
X linked and autosomal recessive forms have also been
observed. Inherited cataracts are clinically highly heterogene-
ous and show considerable inter- and intrafamilial
variability.3–5 To date, more than 15 independent loci and genes
on different chromosomes have been shown to be associated
with autosomal dominant congenital cataracts (ADCC),2 6–9
and causative mutations have been identified in several
distinct genes, including genes encoding crystallins,10–18 lens
specific connexins (gap junction proteins),19–22 aquaporin
(MIP),23 24 and cytoskeletal structural proteins,25 26 as well as in
the homeobox gene PITX327 and the heat shock transcription
factor 4 gene (HSF4).28 Congenital cataracts are genetically
heterogeneous as clinically identical cataracts have been
mapped to different loci.2 29 Conversely, an identical mutation
can result in different phenotypes.5 10 14
Cerulean cataracts, which were first described by Vogt in
1922,30 are characterised by early onset, progressive develop-
ment of bilateral lens opacities and complete penetrance.
Affected newborns appear to be asymptomatic until the age of
18 to 24 months. At this age they can be clinically diagnosed
by slit lamp examination, which shows the presence of tiny
blue or white opacities that first develop in the superficial lay-
ers of the fetal lens nucleus. Armitage et al31 suggested that
cerulean cataracts should be classified as developmental cata-
racts rather than as congenital cataracts. The opacities spread
throughout the adult lens nucleus and cortex and form
concentric layers with radially orientated central lesions.
Two cerulean ADCCs (ADCCC) have been mapped in
distinct, large families: one to 17q24 (CCA1, MIM 115660) and
the other to 22q11.2-q12.2 (CCA2, MIM 601547), which is
close to the β-crystallin gene (CRYBB2, MIM 123620).31 32 Litt et
al10 identified a chain termination mutation in the CRYBB2
gene and showed that this mutation is associated with the
CAA2 type. However, no mutated genes have yet been found to
be associated with the CCA1 type. We recently reported a large
Moroccan pedigree with an unusual form of cerulean blue dot
cataract, characterised by a very early onset of lens opacities
and a rapid progression towards blindness in the absence of
rapid surgical intervention. In this family, we excluded any
linkage to previously mapped loci for ADCCCs (17q24 and
22q).33 We report here the linkage of the ADCCC affecting this
Moroccan family to a region of chromosome 2q33-q35, span-
ning the γ-crystallin gene cluster. We also identified a
missense mutation in the CRYGD gene, causing this precocious
and rapidly progressing form of ADCCC.
MATERIALS AND METHODS
Family data
We have studied a large Moroccan family with ADCCC. The
family consists of 19 affected and 24 unaffected subjects
spanning four generations. Appropriate informed consent was
obtained from all patients participating in the study. Clinical
and ophthalmological examination of patients affected by
cerulean cataract as well as unaffected family members were
carried out as described previously. The diagnosis of cerulean
cataract was confirmed in each affected patient by four inde-
pendent ophthalmologists. There was no history of other ocu-
lar or systemic abnormalities in this family. The clinical
aspects of the present study have been published recently.33
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Blood samples were collected from 43 family members.
Genomic DNA was extracted by standard techniques.
Genotyping and linkage analysis
The genotyping was performed as described previously33 using
firstly 30 microsatellite markers, corresponding to 13 known
candidate loci for autosomal dominant congenital cataracts,
and then 21 markers localised to 2q33-35. The oligonucleotide
primer sequences were taken from Généthon (http://
www.genethon.fr). Two point disease to marker linkage
analysis was conducted by MLINK from the FASTLINK
(version 3.0P) software package.34 The mode of inheritance
was considered to be autosomal dominant with full pen-
etrance. The gene frequency was set at 1/20 000. As the allelic
frequencies of the polymorphic markers were unknown in the
Moroccan population, they were considered to be equal. Order
and genetic distances were taken from the Marshfield
database (http://research.marshfieldclinic.org) and ensembl
genome data resources (http://www.ensembl.org ). Multipoint
analysis was computed using Genehunter software.35
DNA sequencing
Genomic DNA samples from all affected and unaffected fam-
ily members of the pedigree and from control subjects were
screened for mutations in CRYGA, B, C, and D by direct cycle
sequencing. Gene specific PCR primers were used to amplify
the three exons and flanking introns sequences of CRYGA,
CRYGB (sequences available upon request), CRYGC, and
CRYGD.12 15 PCR products were purified by means of “invitro-
gen” rapid PCR purification systems and were sequenced on
ABIprism A310 and ABI A377 automated sequencer (PE Bio-
systems, USA) using the original and additional internal
primers.
Molecular modelling
A model of the P23T mutant structure was built based on the
human γD crystal coordinates using the program “O”36 by
placing the mutant side chain in the most favourable confor-
mation using the side chain database within the program and
using the lego-side chain option. The model was energy mini-
mised using 200 cycles of Powell energy minimisation using
the CNS program37 and the quality of the model was checked
with Procheck.38
RESULTS
We analysed, clinically and genetically, a large Moroccan fam-
ily affected by ADCCC. The congenital cerulean cataract
phenotype was clearly distinct from the phenotypes of the
lamellar, coralliform, aculeiform, Coppock-like, and polymor-
phic congenital cataracts phenotypes.11 15 39–41
Forty-three members of the pedigree, including 20 affected
subjects, 17 unaffected family members, and six unaffected
spouses (fig 1A), were genotyped. The preliminary linkage
analysis performed in this family using 30 microsatellite
markers allowed us to exclude 12 candidate loci for ADCC
(1pter-p36.13, 1q21.2, 1q21.2, 3p21.2-22.3, 10q23.3-25, 12q12-
14.1, 13q11-12, 16q22.1, 17p12-13, 17q11.2-q12.2, 17q24,
21q22.3, and 22q11.2-q12.2) (data not shown). Positive two
point lod scores were obtained for markers D2S72
(Zmax=3.47 at θ=0.01) and CRYGA (Zmax=1.75 at θ=0.00)
(table 1). D2S72 and CRYGA flank the 4.5 cM 2q33-35 interval,
where the loci corresponding to polymorphic congenital cata-
racts (MIM 601286),39 Coppock-like cataracts (MIM 123660,
MIM 116200),40 juvenile onset punctate cataracts (MIM
123690),11 aculeiform congenital cataracts (MIM 115700),41
and variable zonular pulverulent cataracts15 have been
previously mapped. Twenty-one additional markers spanning
this critical interval were subsequently used for further geno-
typing of all family members. The two point lod scores for 10
of these 21 markers are summarised in table 1. Significant
positive lod scores (Zmax>3 at θ=0) were found for 11 mark-
ers. The maximum two point lod score was obtained with
marker D2S2208 (Zmax=7.19 at θ=0.00) (table 1).
Multipoint analysis with the most informative markers
confirmed that this locus mapped to chromosome 2q33-q35
(data not shown).
Haplotype analysis showed that the affected patients of this
family shared a common haplotype involving 12 markers
(D2S2237, D2S155, D2S2358, D2S355, D2S2192, D2S325,
D2S2242, D2S2208, D2S157, CRYGA, D2S22322, D2S128).
Critical recombination events were detected in affected
subjects III.6, III.7, III.11, IV.21, and IV.5. This allowed us to
define a disease gene containing an interval of about 11.5 cM
between markers D2S72 and D2S2361 (fig 1B). All affected
subjects had an affected parent, and no unaffected subjects
carried the disease haplotype. Thus, penetrance appears to be
virtually complete in this family. Several candidate genes have
been mapped in this interval, the obvious one being the
γ-crystallin gene cluster, CRYG, which has been mapped to
2q33-35.42 Another crystallin gene, CRYBA2, has been mapped
to the 2q34-36 region.43 CRYBA2 is 10.5 cM telomeric to CRYGA
and 1 cM telomeric to D2S173. PAX3, a major developmental
gene, is localised 1 cM telomeric to D2S126 and is thus outside
the critical interval. The observation of recombination events,
which are centromeric to these two genes, in our family
excluded the CRYBA2 and PAX3 genes as candidate genes for
the cerulean cataracts affecting this family. Thus, this linkage
analysis identified a third locus (CCA3) associated with the
cerulean blue dot cataract type. This type differs from those
previously described and is characterised by early onset (diag-
nosed at birth) and by a faster progression.
Table 1 Two point lod scores (Z) for linkage between autosomal dominant
congenital cerulean cataract CCA3 and markers in the chromosomal region 2q33-35
Marker
Genetic distance*
(Mb)
Lod score at θ
0.0 0.01 0.05 0.1 0.2 0.3 0.4
D2S116 3.09 –∞ 2.24 3.22 3.27 2.70 1.77 0.70
D2S72 0.87 –∞ 3.47 3.85 3.72 3.07 2.17 1.08
D2S2237 1.32 4.61 4.54 4.24 3.85 2.99 2.02 0.93
D2S155 1.16 5.87 5.77 5.37 4.84 3.72 2.50 1.18
D2S2192 0.61 5.46 5.37 5.01 4.54 3.51 2.38 1.14
D2S2208 0.36 7.19 7.09 6.67 6.11 4.86 3.44 1.82
CRYGA 5.95 1.75 1.71 1.54 1.33 0.88 0.46 0.12
D2S128 1.25 5.72 5.64 5.30 4.84 3.84 2.70 1.41
D2S2361 2.31 –∞ 4.82 5.07 4.77 3.79 2.53 1.09
D2S173 3.16 –∞ 1.29 1.78 1.82 1.56 1.12 0.59
D2S126 –∞ 1.18 2.84 3.18 2.85 2.03 0.95
*Between the adjacent mapped markers.
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Given our linkage analysis results and the fact that
γ-crystallin genes are expressed early in development44 45 and
are associated with hereditary cataracts in mice and
humans,2 6 46–49 we focused on these genes.. The analysis of the
sequences of all three exons of CRYGA, CRYGB, CRYGC, and
CRYGD did not show any disease causing mutations in the
CRYGA, CRYGB, or CRYGC gene in any of the members of this
large family. Only the single nucleotide polymorphisms previ-
ously described were identified, like 2437C/T (M19364)
(P64P) in exon 2 of CRYGB,12 5391C>A (M193364) (L111I) in
exon 3 of CRYGB,17 18229A>G (M19364) (IVS-70 intron A) in
CRYGC,12 and 286T>C (K03005) (Y16Y) in exon 2 of CRYGD.12
A unique heterozygous C>A transversion was identified at
nucleotide 305 in exon 2 (K03005) of the CRYGD gene in all
affected family members. This transversion led to the replace-
ment of a proline residue at amino acid 23 by a threonine
(P23T) in the first “Greek key motif” (motif 1) of the
γD-crystallin protein. This substitution was not found in any
of the unaffected members of the pedigree. This mutation
cosegregated strictly with the trait in the kindred studied with
complete penetrance. This nucleotide sequence alteration was
not found in a panel of 100 unrelated control DNA samples
collected from normal Moroccan subjects or in a panel of 100
unrelated control DNA samples collected from people of vari-
ous ethnic backgrounds. An alignment of γ-crystallin protein
sequences from different species showed that Pro 23 is
conserved in all major human γ-crystallins as well as in rat and
mouse γA, γB, and γC-crystallins and in bovine γB and
γC-crystallins (fig 2C). Furthermore, a threonine is never
found in any crystallin, whatever the species analysed, at this
position. The identified CRYGD proline to a threonine (P23T)
substitution at amino acid 23 is a non-conservative amino acid
change as proline has a hydrophobic side chain.
DISCUSSION
In this report, after excluding most known loci corresponding
to ADCC, we identified a third locus (CCA3) on 2q33-35, asso-
ciated with the cerulean blue dot cataract type in a large
Moroccan family. We then found a C>A transversion in exon
2 of GRYGD only in all affected members of the large family
studied. Crystallin genes encode a superfamily of major solu-
ble structural proteins in the lens. There are three major
classes of crystallins in humans, the α-, β-, and
γ-crystallins.50 51 All three types of crystallins are β pleated
sheets. Protein sequence analysis has shown homology
between the β- and γ-crystallins. The γ-crystallin gene cluster
comprises six genes; γA, γB, γC, γD, γE, and γF. Different levels
of expression of these genes are associated with the lens
refractive index characteristics of the vertebrate enabling
adaptation to varying optical requirements.52 In mammals,
these genes each consist of three exons.53 54 Only γC- and γD
encode abundant lens γ-crystallins in humans.44 45 γE and γF
are pseudogenes with in frame stop codons. γD is one of the
only two γ-crystallins to be expressed at high concentrations
in the fibre cells of the embryonic human lens. These cells
subsequently form the lens nucleus fibres.
The identified C>A transversion found exclusively in all
affected members of the pedigree results in a P23T substitu-
tion. Proline has a hydrophobic side chain often associated
with turns in polypeptide chain conformation, whereas the
threonine side chain has both hydrophilic and hydrophobic
functions. Furthermore, a threonine is never found in any
crystallin, whatever the species analysed, at this position. Pro-
line is known to have a strong ability to break β-strands in
soluble proteins.55 56 These data strongly suggest that the
305C>A transversion is indeed the CCA3 causing mutation
rather than a rare benign polymorphism. It is noteworthy that
the same mutation has recently been suggested to cause an
autosomal dominant congenital form of lamellar cataracts in
a proband and her affected father in a small nuclear Indian
family.17 The difference between the phenotype reported in
this Indian family and that observed in our Moroccan family
may be related to the effect of an unknown modifier gene or to
sequence variations within regulatory regions that could
Figure 1 (A) Pedigree of the large Moroccan family affected by autosomal dominant congenital cerulean cataracts (CCA3). (B) a Markers of
the chromosomal region 2q33-q35 used for linkage analysis. b Common haplotype present in all affected family members. c Haplotypes
observed in patients III.6, III.7, III.11, IV.5 and IV.21, displaying critical recombination events. Asterisks indicate subjects who underwent
linkage analysis.
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affect the expression of the γD-crystallin gene. This pheno-
typic heterogeneity caused by an identical genetic crystallin
mutation is strongly reminiscent of that previously reported
for the βB2-crystallin gene. The same chain termination
mutation in the βB2-crystallin gene caused autosomal domi-
nant congenital Coppock-like cataracts in a four generation
Swiss family14 and autosomal dominant congenital cerulean
cataracts (CCA2) in a very large American family.10 32 57 These
data further strengthen the hypothesis that the γD-crystallin
P23T mutation is pathogenic and prompted us to try to obtain
further insights into the molecular mechanisms underlying
cataractogenesis in the large Moroccan kindred studied.
Figure 2 Mutation analysis of CRYGD. (A) Sequence
chromatograms of the wild type allele showing a proline (CCC) at
amino acid 23. (B) Sequence chromatograms of the mutant allele
showing the C to A transversion that changed proline 23 to
threonine. (C) Sequence alignment of the γ-crystallin proteins in
different species. Shown below are the amino acid residues 12-33
and 45-53 of human γD-crystallin. Proline 23 of human CRYGD
protein is underlined and appears in bold type. The arrow indicates
the P23T mutated position. Residues in the other γ-crystallins identical
to those at homologous positions of human CRYGD are indicated by
dots. Figure 3 (A) Cartoon topology diagram of the characteristic
domain structure found in all βγ-crystallins showing how two “Greek
key motifs”, each comprising four β-strands (a, b, c, and d),
associate to form two β-sheets. The red circle shows the site of the
P23T mutation in the N-terminal domain of γD-crystallin. (B)
Schematic view of the protein fold determined by x ray
crystallography centred on residue P23 and looking along β-sheet 2
of the normal CRYGD protein. (C) The same view centred on the
mutation site but based on a predicted structure modelled on the
crystallographic coordinates of the normal CRYGD protein. Light blue
= β-sheet strands, green = loops connecting β-sheet strands, dashed
green lines = hydrogen bonds between the region adjacent to the
β-sheet c strand and residues in the folded ab β-hairpin, dashed
yellow lines = local hydrogen bond in the region of the β-sheet c
strand, red = oxygen atoms and blue = nitrogen atoms.
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The 3D structures of several members of the monomeric
γ-crystallin family are known, showing that the polypeptide
folds into four similar “Greek key motifs”. These motifs then
form two similar domains joined by a linker (recently
reviewed in Jaenicke et al 58). The 3D structure of human
γD-crystallin has now been determined at a very high resolu-
tion (1.25 Å) by x ray crystallography.59 We may try to gain
some insight into the pathogenicity of the P23T γD-crystallin
mutation from the crystallographic structure of the native
human protein. Its conformation is very similar to that of
γ-crystallins from other species60 and, as expected, very similar
to that of the orthologous bovine γD.61 Each γ-crystallin
domain is formed from two consecutive Greek key motifs and
each motif comprises four consecutive β-strands. Thus, the
N-terminal domain can be described as comprising a1 b1 c1
d1 and a2 b2 c2 d2 β-strands. These eight β-strands form two
β-sheets (b1 a1 d1 c2 and b2 a2 d2 c1) that pack together to
form a β-sandwich domain. Although β-sandwich domains
are common in proteins, in βγ-crystallins they are character-
ised by their high internal conformational symmetry and by a
conserved folded hairpin structure between a and b β-strands.
The mutation affects a region of the first Greek key motif that
is located immediately after the c1 strand, a region that is
important for determining the topology of this protein fold, as
after crossing from one β-sheet to the next the polypeptide
chain has to get back to the original β-sheet to place the d1
strand within it. Obviously, a single Greek key cannot fold on
its own; it is dependent on the concomitant folding of its part-
ner motif. The degree of sequence conservation of residue 23
in motif 1 and the corresponding region in the other three
motifs gives an idea of the importance of this region. Although
not absolutely conserved, this residue tends to be a proline or
a serine in motifs 1, 2, and 3, whereas it is an arginine in motif
4. The mutation site thus substitutes a threonine residue into
a strategic position in terms of the fold topology, a site that has
been occupied, however, by a very similar residue, serine. Fig 3
shows the N-terminal domain along the second β-sheet from
the edge of the short c1 strand and centred around residue 23.
In wild type human γD-crystallin, the carbonyl oxygen of Pro
23 forms a hydrogen bond with the backbone amide nitrogen
of Asn 49 (fig 3B). This backbone interaction helps to stabilise
the folded ab hairpin onto the sheet and is thus an important
tertiary structure determinant. However, as it involves only
backbone interactions, it is not affected by side chain
alterations, assuming that in the mutant structure the
backbone is in the same conformation as in the native struc-
ture. When threonine is modelled into this position, the new
side chain is readily accommodated into the space without
changing the backbone conformation (fig 3C). Threonine is
more polar than proline as it has a polar backbone amide
nitrogen and a side chain hydroxyl function. In this predicted
model the mutant side chain appears to strengthen the inter-
action with tyrosine 50. The aromatic side chain of this residue
can play an important role in stabilising the folded ab hairpin.
Threonine 23 can make a stronger hydrogen bond with the
side chain hydroxyl function of Tyr 50 using its backbone
amide as well as an additional hydrogen bond with its own
side chain hydroxyl. It is difficult to imagine that the mutation
has such a catastrophic effect on the 3D structure of the
human γD-crystallin based on this model. There are three
possible scenarios: the protein does not fold properly because
a side chain with a branched Cβ atom has a propensity to
extend the β-strand rather than make the necessary turn; the
substitution of threonine decreases the thermodynamic
stability of the N-terminal domain in a subtle way so that the
protein is more prone to denaturation; or thirdly the threonine
side chain somehow decreases the solubility of the protein in
water. The discovery of this mutation site, with its major clini-
cal consequences, challenges our understanding of crystallin
structure. This is clearly shown also by studies on other cata-
ractogenic mutations of human γD-crystallin; recent biophysi-
cal studies suggest that the R14C γD-crystallin mutant
increases the phase separation temperature62 and that the two
γD-crystallin mutant proteins, R58H and R36S, crystallise far
more readily than the native protein.63 However, none of these
mutant proteins has been shown to change the conformation
of the protein significantly. In contrast, the T5P CRYGC
mutant protein induces obvious folding changes and de-
creases conformational stability.64 Thus, further biophysical
characterisation of the P23T mutant protein is important to
provide more information about the nature of the disease and
improve our understanding of the molecular phenotype of
lens crystallins.
ACKNOWLEDGEMENTS
We are grateful to the members of the family for their participation in
this study. We warmly thank Dr Jayanti Pande for critical reading of
the manuscript. We thank Université René Descartes and Professor
Patrick Berche, Dean of Faculté de Médecine Necker for his
permanent support for the CERTO Laboratory. We thank Ibn Tofail
University, Faculty of Sciences of Kénitra and Centre National pour la
Recherche Scientifique et Technique of Morocco. We thank Professor
Jean-Louis Dufier for his constant encouragement and efforts for the
development of the CERTO Laboratory. We also thank Dr Cécile Mar-
sac and Dr Maurice Menasche for their scientific support. We thank all
members of the medical staff of the Department of Ophthalmology B
(Hôpital des Spécialités de Rabat, Morocco). This work was mainly
supported by a grant to the CERTO Laboratory from RETINA France
and also by a “Programme d’Appui à la Recherche Scientifique” (Pars
Médecine No 151), by a research grant from INSERM (Programme
PROGRES), and by several grants from Faculté de Médecine Necker
and Université René Descartes. Emeline Nandrot has been supported
by a PhD grant from RETINA-France for three years and by a PhD
grant for one year from Fondation pour la Recherche Médicale. We
gratefully acknowledge the finacial support of the Medical Research
Council, London.
. . . . . . . . . . . . . . . . . . . . .
Authors’ affiliations
E Nandrot, L Arbogast, M Abitbol, Centre de Recherches
Thérapeutiques en Ophtalmologie de la Faculté de Médecine Necker, EA
No 2502 du Ministère de la Recherche et de l’Enseignement Supérieur,
Université René Descartes, Paris, France
C Slingsby, A Basak, Birkbeck College, Department of Crystallography,
Malet Street, London WC1E 7HX, UK
M Cherif-Chefchaouni, A Berraho Département
d’Oto-Neuro-Ophtalmologie, Service d’Ophtalmologie B, Hôpital des
Spécialités, Rabat, Morocco
B Benazzouz, Y Hajaji, S Boutayeb, L Hilal, Laboratoire de Génétique
et Biologie Moléculaire de la Faculté des Sciences, Université Ibn Tofail,
Kénitra, Morocco
O Gribouval, Unité INSERM 423, CHU Necker-Enfants Malades, Paris,
France
REFERENCES
1 Lambert SR, Drack AV. Infantile cataracts. Surv Ophthalmol
1996;40:427-58.
2 Francis PJ, Berry V, Bhattacharya SS, Moore AT. The genetics of
childhood cataract. J Med Genet 2000;37:481-8.
3 Merin S. Inherited eye diseases: diagnosis and clinical management. In:
Dekker NYM, ed. Inherited cataracts. Chapter 4. New York: Marcel
Dekker 1991.
4 Scott MH, Hejtmancik JF, Wozencraft LA, Wozencraft LA, Reuter LM,
Parks MM Kaiser-Kupfer MI. Autosomal dominant congenital cataract.
Interocular phenotypic variability. Ophthalmology 1994;101:866-71.
5 Vanita. Genetical investigations in congenital cataract cases. Amritsar,
India: Guru Nanak, 1998.
6 Hejtmancik JF. The genetics of cataract: our vision becomes clearer. Am
J Hum Genet 1998;62:520-5.
7 Ionides A, Berry V, Mackay D, Shiels A, Bhattacharya S, Moore A.
Anterior polar cataract: clinical spectrum and genetic linkage in a single
family. Eye 1998;12(Pt 2):224-6.
8 Vanita, Singh JR, Sarhadi VK, Singh D, Reis A, Rueschendorf F,
Becker-Follmann J, Jung M, Sperling K. A novel form of “central
pouchlike” cataract, with sutural opacities, maps to chromosome
15q21-22. Am J Hum Genet 2001;68:509-14.
9 Vanita, Sarhadi V, Reis A, Jung M, Singh D, Sperling K, Singh, J. R.
Burger JA unique form of autosomal dominant cataract explained by
gene conversion between beta-crystallin B2 and its pseudogene. J Med
Genet 2001;38:392-6.
10 Litt M, Carrero-Valenzuela R, LaMorticella DM, Schultz DW, Mitchell TN,
Kramer P, Maumenee IH. Autosomal dominant cerulean cataract is
266 Nandrot, Slingsby, Basak, et al
www.jmedgenet.com
associated with a chain termination mutation in the human beta-crystallin
gene CRYBB2. Hum Mol Genet 1997;6:665-8.
11 Stephan DA, Gillanders E, Vanderveen D, Freas-Lutz D, Wistow G,
Baxevanis AD, Robbins CM, VanAuken, A, Quesenberry MI,
Bailey-Wilson J, Juo SH, Trent JM, Smith L, Brownstein MJ. Progressive
juvenile-onset punctate cataracts caused by mutation of the
gammaD-crystallin gene. Proc Natl Acad Sci USA 1999;96:1008-12.
12 Heon E, Priston M, Schorderet DF, Billingsley GD, Girard PO, Lubsen,
N, Munier FL. The gamma-crystallins and human cataracts: a puzzle
made clearer. Am J Hum Genet 1999;65:1261-7.
13 Bateman JB, Geyer DD, Flodman P, Johannes M, Sikela J, Walter N,
Moreira AT, Clancy K, Spence, MA .A new betaA1-crystallin splice
junction mutation in autosomal dominant cataract. Invest Ophthalmol Vis
Sci 2000;41:3278-85.
14 Gill D, Klose R, Munier FL, McFadden M, Priston M, Billingsley G,
Ducrey N, Schorderet DF, Heon, E. Genetic heterogeneity of the
Coppock-like cataract: a mutation in CRYBB2 on chromosome 22q11.2.
Invest Ophthalmol Vis Sci 2000;41:159-65.
15 Ren Z, Li A, Shastry BS, Padma T, Ayyagari R, Scott MH, Parks MM,
Kaiser-Kupfer MI, Hejtmancik JF. A 5-base insertion in the
gammaC-crystallin gene is associated with autosomal dominant variable
zonular pulverulent cataract. Hum Genet 2000;106:531-7.
16 Berry V, Francis P, Reddy MA, Collyer D, Vithana E, MacKay I, Dawson
G, Carey AH, Moore A, Bhattacharya SS, Quinlan RA. Alpha-B crystallin
gene (CRYAB) mutation causes dominant congenital posterior polar
cataract in humans. Am J Hum Genet 2001;69:1141-5.
17 Santhiya ST, Shyam Manohar M, Rawlley D, Vijayalakshmi P,
Namperumalsamy P, Gopinath PM, Loster J, Graw J .Novel mutations in
the gamma-crystallin genes cause autosomal dominant congenital
cataracts. J Med Genet 2002;39:352-8.
18 Mackay DS, Boskovska OB, Knopf HL, Lampi KJ, Shiels, A. A nonsense
mutation in CRYBB1 associated with autosomal dominant cataract linked
to human chromosome 22q. Am J Hum Genet 2002;71:1216-21.
19 Shiels A, Mackay D, Ionides A, Berry V, Moore A, Bhattacharya S. A
missense mutation in the human connexin50 gene (GJA8) underlies
autosomal dominant “zonular pulverulent” cataract, on chromosome 1q.
Am J Hum Genet 1998;62:526-32.
20 Mackay D, Ionides A, Kibar Z, Rouleau G, Berry V, Moore A, Shiels A,
Bhattacharya S. Connexin46 mutations in autosomal dominant
congenital cataract. Am J Hum Genet 1999;64:1357-64.
21 Rees MI, Watts P, Fenton I, Clarke A, Snell RG, Owen MJ, Gray J.
Further evidence of autosomal dominant congenital zonular pulverulent
cataracts linked to 13q11 (CZP3) and a novel mutation in connexin 46
(GJA3). Hum Genet 2000;106:206-9.
22 Polyakov AV, Shagina IA, Khlebnikova OV, Evgrafov OV. Mutation in
the connexin 50 gene (GJA8) in a Russian family with zonular pulverulent
cataract. Clin Genet 2001;60:476-8.
23 Berry V, Francis P, Kaushal S, Moore A, Bhattacharya S. Missense
mutations in MIP underlie autosomal dominant ’polymorphic’ and
lamellar cataracts linked to 12q. Nat Genet 2000;25:15-7.
24 Francis P, Chung JJ, Yasui M, Berry V, Moore A, Wyatt MK, Wistow G,
Bhattacharya SS, Agre, P. Functional impairment of lens aquaporin in
two families with dominantly inherited cataracts. Hum Mol Genet
2000;9:2329-34.
25 Conley YP, Erturk D, Keverline A, Mah TS, Keravala A, Barnes LR,
Bruchis A, Hess JF, FitzGerald PG, Weeks DE, Ferrell RE, Gorin MB. A
juvenile-onset, progressive cataract locus on chromosome 3q21-q22 is
associated with a missense mutation in the beaded filament structural
protein-2. Am J Hum Genet 2000;66:1426-31.
26 Jakobs PM, Hess JF, FitzGerald PG, Kramer P, Weleber RG, Litt M.
Autosomal-dominant congenital cataract associated with a deletion
mutation in the human beaded filament protein gene BFSP2. Am J Hum
Genet 2000;66:1432-6.
27 Semina EV, Ferrell RE, Mintz-Hittner HA, Bitoun P, Alward WL, Reiter
RS, Funkhauser C, Daack-Hirsch S, Murray J. A novel homeobox gene
PITX3 is mutated in families with autosomal-dominant cataracts and
ASMD. Nat Genet 1998;19:167-70.
28 Bu L, Jin Y, Shi Y, Chu R, Ban A, Eiberg H, Andres L, Jiang H, Zheng G,
Qian M, Cui B, Xia Y, Liu J, Hu L, Zhao G, Hayden MR, Kong, X. Mutant
DNA-binding domain of HSF4 is associated with autosomal dominant
lamellar and Marner cataract. Nat Genet 2002;31:276-8.
29 He W, Li S. Congenital cataracts: gene mapping. Hum Genet
2000;106:1-13.
30 Vogt A. Weitere Ergebnisse der Spaltlampenmikroskopie des vorderen
Bulbusabschnittes. III (Abschnitt-Fortsetzung). Angeborene und fruh
aufgetretene Linsenveranderungen. Graefe Arch Klin Exp Ophthal
1922;108:182-91.
31 Armitage MM, Kivlin JD, Ferrell RE. A progressive early onset cataract
gene maps to human chromosome 17q24. Nat Genet 1995;9:37-40.
32 Kramer P, Yount J, Mitchell T, LaMorticella D, Carrero-Valenzuela R,
Lovrien E, Maumenee I, Litt M. A second gene for cerulean cataracts
maps to the beta crystallin region on chromosome 22. Genomics
1996;35:539-42.
33 Hilal L, Nandrot E, Belmekki M, Cherif-Chefchaouni M, El Bacha S,
Benazzouz B, Hajaji Y, Gribouval O, Dufier JL, Abitbol M, Berraho A.
Evidence of clinical and genetic heterogeneity in autosomal dominant
congenital cerulean cataracts. Ophthal Genet 2002;22:199-208.
34 Lathrop GM, Lalouel JM. Easy calculations of lod scores and genetic
risks on small computers. Am J Hum Genet 1984;36:460-5.
35 Cottingham RW, Jr., Idury RM, Schaffer AA. Faster sequential genetic
linkage computations. Am J Hum Genet 1993;53:252-63.
36 Jones TA, Kjelgaard M. Electron density map interpretation. Methods
Enzymol 1997;277:173-208.
37 Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P,
Grosse-Kunstleve RW, Jiang JS, Nilges M, Pannu NS, Read RJ, Rice LM,
Simonson T, Warren GL. Crystallography & NMR system: a new software
suite for macromolecular structure determination. Acta Crystallogr
1998;D54:905-21.
38 Laskowski RA, MacArthur MW, Moss DS, Thornton JM. A program to
check the stereochemical quality of protein structures. J Appl Crystallogr
1993;26:283-91.
39 Rogaev EI, Rogaeva EA, Korovaitseva G, Farrer LA, Petrin, AN,
Keryanov SA, Turaeva S, Chumakov I, St George-Hyslop, P, Ginter EK.
Linkage of polymorphic congenital cataract to the gamma-crystallin gene
locus on human chromosome 2q33-35. Hum Mol Genet
1996;5:699-703.
40 Lubsen NH, Renwick JH, Tsui LC, Breitman ML, Schoenmakers JG. A
locus for a human hereditary cataract is closely linked to the
gamma-crystallin gene family. Proc Natl Acad Sci USA
1987;84:489-92.
41 Heon E, Liu S, Billingsley G, Bernasconi O, Tsilfidis C, Schorderet DF,
Munier FL, Tsifildis C. Gene localization for aculeiform cataract, on
chromosome 2q33-35. Am J Hum Genet 1998;63:921-6.
42 Shiloh Y, Donlon T, Bruns G, Breitman ML, Tsui LC. Assignment of the
human gamma-crystallin gene cluster (CRYG) to the long arm of
chromosome 2, region q33-36. Hum Genet 1986;73:17-19.
43 Hulsebos TJ, Cerosaletti KM, Fournier RE, Sinke RJ, Rocchi M, Marzella
R, Jenkins NA, Gilbert DJ, Copeland, NG. Identification of the human
beta A2 crystallin gene (CRYBA2): localization of the gene on human
chromosome 2 and of the homologous gene on mouse chromosome 1.
Genomics 1995;28:543-8.
44 Russell P, Meakin SO, Hohman T, Tsui LC, Breitman ML. Relationship
between proteins encoded by three human gamma-crystallin genes and
distinct polypeptides in the eye lens. Mol Cell Biol 1987;7:3320-3.
45 Brakenhoff RH, Aarts HJ, Reek FH, Lubsen NH, Schoenmakers JG.
Human gamma-crystallin genes. A gene family on its way to extinction. J
Mol Biol 1990;216:519-32.
46 Graw J. Cataract mutations as a tool for developmental geneticists.
Ophthalmic Res 1996;28(suppl 1):8-18.
47 Graw J. Cataract mutations and lens development. Prog Retin Eye Res
1999;18:235-67.
48 Graw J, Loster J, Soewarto D, Fuchs H, Meyer B, Reis A, Wolf E, Balling
R, de Angelis MH. Characterization of a new, dominant V124E mutation
in the mouse alphaA-crystallin-encoding gene. Invest Ophthalmol Vis Sci
2001;42:2909-15.
49 Graw J, Klopp N, Neuhauser-Klaus A, Favor J, Loster J. Crygf(Rop): the
first mutation in the Crygf gene causing a unique radial lens opacity.
Invest Ophthalmol Vis Sci 2002;43:2998-3002.
50 van Rens GL, de Jong WW, Bloemendal H. A superfamily in the
mammalian eye lens: the beta/gamma-crystallins. Mol Biol Rep
1992;16:1-10.
51 Slingsby C, Clout NJ. Structure of the crystallins. Eye 1999;13(Pt
3b):395-402.
52 Wistow GJ. Molecular biology and evolution of crystallins: gene
recruitment and multifunctional proteins in the eye lens. Austin (TX): R G
Landes, 1995.
53 Graw J. The crystallins: genes, proteins and diseases. Biol Chem
1997;378:1331-48.
54 Wistow GJ, Piatigorsky J. Lens crystallins: the evolution and expression
of proteins for a highly specialized tissue. Annu Rev Biochem
1988;57:479-504.
55 Chou PY, Fasman GD. Prediction of the secondary structure of proteins
from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol
1978;47:45-148.
56 Chou PY, Fasman GD. Empirical predictions of protein conformation.
Annu Rev Biochem 1978;47:251-76.
57 Bodker FS, Lavery MA, Mitchell TN, Lovrien EW, Maumenee IH.
Microphthalmos in the presumed homozygous offspring of a first cousin
marriage and linkage analysis of a locus in a family with autosomal
dominant cerulean congenital cataracts. Am J Med Genet
1990;37:54-9.
58 Jaenicke R, Slingsby C. Lens crystallins and their microbial homologs:
structure, stability, and function. Crit Rev Biochem Mol Biol
2001;36:435-99.
59 Basak A, Bateman O, Slingsby C, Pande A, Asherie N, Ogun O,
Benedek GB, Pande J. High-resolution x-ray crystal structures of human γD
crystallin (1.25Å) and the R58H mutant (1.15Å) associated with
aculeiform cataract. (Submitted.)
60 Norledge BV, Trinkl S, Jaenicke R, Slingsby C. The x-ray structure of a
mutant eye lens beta B2-crystallin with truncated sequence extensions.
Protein Sci 1997;6:1612-20.
61 Chirgadze YN, Driessen, HPC, Wright G, Slingsby C, Hay RE, Lindley
PF. Structure of the bovine eye lens γD (γIIIb)-crystallin at 1.95 Å Acta
Cryst 1996;D52:712-21.
62 Pande A, Pande J, Asherie N, Lomakin A, Ogun O, King JA, Lubsen
NH, Walton D, Benedek GB. Molecular basis of a progressive
juvenile-onset hereditary cataract. Proc Natl Acad Sci USA
2000;97:1993-8.
63 Pande A, Pande J, Asherie N, Lomakin A, Ogun O, King J, Benedek GB.
Crystal cataracts: human genetic cataract caused by protein
crystallization. Proc Natl Acad Sci USA 2001;98:6116-20.
64 Fu L, Liang JJ. Conformational change and destabilization of cataract
gammaC-crystallin T5P mutant. FEBS Lett 2002;513:213-16.
A CRYGD mutation in cerulean cataracts 267
www.jmedgenet.com
